Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis (Q33607506)

28 July 2017

0 references

Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis (English)

1 reference

28 July 2017

0 references

1

S R Salpeter

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 November 1993

1 reference

Western Journal of Medicine

28 July 2017

published in

1 reference

28 July 2017

volume

159

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

560-564

1 reference

Risk Factors for Isoniazid (INH)-Induced Liver Dysfunction

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Isoniazid-associated hepatitis. Report of an outbreak

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Isoniazid toxicity. A prospective study in secondary chemoprophylaxis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Controlled chemoprophylaxis trials in tuberculosis. A general review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

The Effect of Isoniazid on Transaminase Levels

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Isoniazid prophylaxis and deaths in Baltimore, 1972.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Active tuberculosis after isoniazid chemoprophylaxis of Southeast Asian refugees.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Tuberculosis prevention: cost-effectiveness analysis of isoniazid chemoprophylaxis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Twenty isoniazid-associated deaths in one state

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Isoniazid hepatitis among pregnant and postpartum Hispanic patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Evaluation of a tuberculosis screening and prophylaxis program for international students

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Decision analysis, public health policy, and isoniazid chemoprophylaxis for young adult tuberculin skin reactors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Preventive therapy for tuberculosis in Maryland

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Isoniazid Preventive Therapy for Tuberculosis: Decision Analysis Considering Ethnicity and Gender

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Isoniazid-associated hepatitis deaths: a review of available information

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Tuberculosis chemoprophylaxis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Isoniazid hepatitis in adolescents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Chemoprophylaxis in inactive tuberculosis: long-term evaluation of a Canadian trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

21 June 2018

How safe is isoniazid?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Isoniazid liver injury during chemoprophylaxis in children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Hepatic Dysfunction During Isoniazid Chemoprophylaxis in Renal Allograft Recipients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Isoniazid Hepatotoxicity in Children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1022345

Liver enzyme disturbances during isoniazid chemoprophylaxis in children

21 June 2018

1 reference

12 December 2020

A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test

1 reference

12 December 2020

Isoniazid preventive therapy: Retrospect and prospect

1 reference

12 December 2020

Should Young Adults with a Positive Tuberculin Test Take Isoniazid?

1 reference

12 December 2020

Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis

1 reference

12 December 2020

Decision analysis for tuberculosis preventive treatment in nursing homes

1 reference

12 December 2020

Isoniazid for the tuberculin reactor: take it or leave it

1 reference

12 December 2020

Isoniazid preventive therapy for tuberculosis. Are we losing our enthusiasm?

1 reference

12 December 2020

Smear- and culture-negative pulmonary tuberculosis: four-month short-course chemotherapy

1 reference

12 December 2020

Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis

1 reference

12 December 2020

Random variation in tuberculin sensitivity in schoolchildren. Serial skin testing before and after preventive treatment for tuberculosis

1 reference

12 December 2020

Compliance with isoniazid prophylaxis in jail

1 reference

12 December 2020

Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin

1 reference

12 December 2020

The benefits of isoniazid chemoprophylaxis and risk factors for tuberculosis among Oglala Sioux Indians

1 reference

12 December 2020

Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis

1 reference

12 December 2020

Isoniazid in the prevention and treatment of tuberculosis. A 20-year study of the effectiveness in children

1 reference

12 December 2020

Why tuberculosis is not prevented

1 reference

12 December 2020

Identifiers

PMC publication ID

1022345

1 reference

28 July 2017

1 reference